By Dean Seal

Shares of Cellebrite advanced on Thursday despite the company cutting its revenue guidance as it swung to a second-quarter profit and said its interim chief executive will remain in the seat permanently.

The stock was up 8.7% at $15.21 in the afternoon session. Shares are still down 31% since the start of the year.

The Israel-based company, which makes software that can retrieve data from phones, said before the opening bell that it now expects $465 million to $475 million in revenue this year, down from prior guidance for $470 million to $485 million.

While the company is benefiting from stronger federal spending, it needs that demand to convert to contracted spending before its top line gets a real boost, Chief Financial Officer David Barter said.

But the second quarter was strong thanks to increased adoption across its global customer base, Barter said.

Cellebrite posted a quarterly profit of $19.5 million, or 8 cents a share, compared with a loss of $23.8 million, or 12 cents a share, in the same quarter a year earlier.

Revenue jumped 18% to $113.3 million, more than $1 million higher than analyst forecasts, according to FactSet.

Cellebrite also said that Thomas Hogan, its interim CEO since January, is ditching the interim designation.

Hogan served as executive chairman from 2023 until Yossi Carmil, Cellebrite's longtime CEO, stepped down earlier this year. About a month earlier, Hogan finished final treatments for Stage 4 cancer, which is now in complete remission, Chairman Adam Clammer said on a call with analysts on Thursday.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

August 14, 2025 15:09 ET (19:09 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.